Association of IL -4-590 C > T and IL -13-1112 C > T gene polymorphisms with the susceptibility to type 2 diabetes mellitus

Disease Markers

Volumn 35, Issue 4, 2013, Pages 243-247

  Alsaid, Afaf ^a   El Missiry, Mohammed ^b   Hatata, El Sayed ^c   Tarabay, Mohammad ^b   Settin, Ahmad ^a,d  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b Mansoura University   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DNA; IL 13 1112; IL 4 590; INTERLEUKIN 13; INTERLEUKIN 4; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ALLELE SPECIFIC POLYMERASE CHAIN REACTION; ARTICLE; CODOMINANCE; CONSANGUINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; DOMINANT INHERITANCE; EGYPT; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; WILD TYPE;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84884938393     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/107470     Document Type: Article

References (22)

1. Doria A., Patti M.-E., Kahn C. R., The emerging genetic architecture of type 2 diabetes. Cell Metabolism 2008 8 3 186 200 2-s2.0-50049086521 10.1016/j.cmet.2008.08.006
2. Voehringer D., Reese T. A., Huang X., Shinkai K., Locksley R. M., Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. Journal of Experimental Medicine 2006 203 6 1435 1446 2-s2.0-33745036694 10.1084/jem.20052448
3. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., Kinoshita S., Association of combined IL-13/IL-4R signaling pathway gene polymorphism with stevens-johnson syndrome accompanied by ocular surface complications. Investigative Ophthalmology and Visual Science 2007 49 5 1809 1813
4. Ueta M., Sotozono C., Inatomi T., Kojima K., Hamuro J., Kinoshita S., Association of combined IL-13/IL-4R signaling pathway gene polymorphism with stevens-johnson syndrome accompanied by ocular surface complications. Investigative Ophthalmology and Visual Science 2008 495 5 1809 1813 2-s2.0-44649130287 10.1167/iovs.07-1401
5. Daneshmandi S., Pourfathollah A., Arababadi M. K., Hassanshahi G., Rezaeian M., Asiabanha M., Evaluation of relation between IL-4 and IFN- γ polymorphisms and type 2 diabetes. Journal of Mazandaran University of Medical Sciences 2008 18
6. Howard T. D., Whittaker P. A., Zaiman A. L., Koppelman G. H., Xu J., Hanley M. T., Meyers D. A., Postma D. S., Bleecker E. R., Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a dutch population. American Journal of Respiratory Cell and Molecular Biology 2001 25 3 377 384 2-s2.0-0034808223
7. Stanya K. J., Jacobi D., Liu S., Direct control of hepatic glucose production by interleukin-13 in mice. Journal of Clinical Investigation 2013 123 1 261 271
8. Maier L. M., Chapman J., Howson J. M. M., Clayton D. G., Pask R., Strachan D. P., McArdle W. L., Twells R. C. J., Todd J. A., No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. American Journal of Human Genetics 2005 76 3 517 521 2-s2.0-13844269028 10.1086/428387
9. Alberti K. G., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications-part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539 553
10. Howell W. M., Turner S. J., Theaker J. M., Bateman A. C., Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. European Journal of Immunogenetics 2003 30 6 409 414 2-s2.0-0346880454 10.1111/j.1365-2370.2003.00425.x
11. Hummelshoj T., Bodtger U., Datta P., Malling H. J., Oturai A., Poulsen L. K., Ryder L. P., Sorensen P. S., Svejgaard E., Svejgaard A., Association between an interleukin-13 promoter polymorphism and atopy. European Journal of Immunogenetics 2003 30 5 355 359 2-s2.0-0242362647 10.1046/j.1365-2370.2003. 00416.x
12. Skopiński P., Rogala E., Duda-Król B., Lipińska A., Sommer E., Chorostowska-Wynimko J., Szaflik J., Partyka I., Skopińska- Rózewska E., Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. Journal of Diabetes and Its Complications 2005 19 6 335 338 2-s2.0-27644541927 10.1016/j.jdiacomp.2005.02.008
13. Nosratabadi R., Arababadi M. K., Hassanshahi G., Yaghini N., Pooladvand V., Shamsizadeh A., Zarandi E. R., Hakimi H., Evaluation of IFN- γ serum level in nephropatic type 2 diabetic patients. Pakistan Journal of Biological Sciences 2009 12 9 746 749 2-s2.0-67651094224 10.3923/pjbs.2009.746.749
14. Ho K.-T., Shiau M.-Y., Chang Y.-H., Chen C.-M., Yang S.-C., Huang C.-N., Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus. Metabolism 2010 59 12 1717 1722 2-s2.0-78549296363 10.1016/j.metabol.2010.04.010
15. Bid H., Konwar R., Agrawal C., Banerjee M., Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian Journal of Medical Sciences 2008 62 7 259 266 2-s2.0-48249112526 10.4103/0019-5359.42021
16. Arababadi M. K., Pourfathollah A. A., Daneshmandi S., Evaluation of relation between IL-4 and IFN- γ polymorphisms and type 2 diabetes. Iranian Journal of Basic Medical Sciences 2009 12 2 100 104
17. Calle M. C., Fernandez M. L., Inflammation and type 2 diabetes. Diabetes and Metabolism 2012 38 3 183 191 2-s2.0-84855573795 10.1016/j.diabet.2011.11.006
18. Cui L., Jia J., Ma C.-F., Li S.-Y., Wang Y.-P., Guo X.-M., Li Q., Yu H.-B., Liu W.-H., Gao L.-B., IL-13 polymorphisms contribute to the risk of asthma: a meta-analysis. Clinical Biochemistry 2012 45 4-5 285 288 2-s2.0-84857657118 10.1016/j.clinbiochem.2011.12.012
19. Kim H.-B., Lee Y.-C., Lee S.-Y., Jung J., Jin H.-S., Kim J.-H., Kim B.-S., Kang M.-J., Jang S.-O., Kim J., Kimm K., Shin E.-S., Lee S.-G., Hong S.-J., Gene-gene interaction between IL-13 and IL-13R α 1 is associated with total IgE in Korean children with atopic asthma. Journal of Human Genetics 2006 51 12 1055 1062 2-s2.0-33751268833 10.1007/s10038-006-0061-x
20. + Th17 cells in patients with type 1 diabetes. Human Immunology 2013 74 6 701 707
21. Imam K., Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Advances in Experimental Medicine and Biology 2012 771 340 355
22. La Torre D., Immunobiology of beta-cell destruction. Advances in Experimental Medicine and Biology 2012 771 194 218